Priya Bhosale1, Jingfei Ma2, Revathy Iyer1, Preetha Ramalingam3, Wei Wei4, Pamela Soliman4, Michael Frumovitz5, Vikas Kundra1. 1. Department of Diagnostic Radiology, the University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA. 2. Department of Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA. 3. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA. 4. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA. 5. Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Abstract
PURPOSE: To compare the clinical usefulness of reduced field-of-view diffusion-weighted imaging (rFOV) with other imaging techniques in determining the depth of myometrial invasion (DMI) in endometrial cancer. MATERIALS AND METHODS: In this prospective study we reviewed 3T magnetic resonance images of 51 patients with clinical Stage I endometrial cancer who underwent total abdominal hysterectomy with bilateral salphingoopherectomy within 3 days after imaging. rFOV with apparent diffusion coefficient reconstruction was obtained in three standard planes followed by sagittal T2 -weighted (T2 WI) images and 3D dynamic T1 -weighted and contrast-enhanced imaging (DCE MRI). Two radiologists with expertise in imaging gynecologic cancers evaluated images independently. The DMI was recorded on imaging and correlated with surgical pathology results. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for DMI were calculated (<50% vs. >50%). RESULTS: Compared with sagittal T2 WI + DCE MRI, rFOV imaging yielded greater specificity (82.2% vs. 90.0%, positive predictive value (42.8% vs. 60.0%), and accuracy (84.0% vs. 92%) for DMI determined by reader 1 and greater the sensitivity (83.3% vs. 100%) for DMI determined by reader 2. The error of measurement of DMI as a continuous variable in millimeters did not differ significantly between the rFOV and pathology results (P < 0.21). However, there was a statistically significant difference for the DMI measured on the dynamic sequence. The DMI on DCE was greater than that seen on pathology at P = 0.02. CONCLUSION: rFOV can be used to assess DMI in clinical Stage I endometrial cancer.
PURPOSE: To compare the clinical usefulness of reduced field-of-view diffusion-weighted imaging (rFOV) with other imaging techniques in determining the depth of myometrial invasion (DMI) in endometrial cancer. MATERIALS AND METHODS: In this prospective study we reviewed 3T magnetic resonance images of 51 patients with clinical Stage I endometrial cancer who underwent total abdominal hysterectomy with bilateral salphingoopherectomy within 3 days after imaging. rFOV with apparent diffusion coefficient reconstruction was obtained in three standard planes followed by sagittal T2 -weighted (T2 WI) images and 3D dynamic T1 -weighted and contrast-enhanced imaging (DCE MRI). Two radiologists with expertise in imaging gynecologic cancers evaluated images independently. The DMI was recorded on imaging and correlated with surgical pathology results. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for DMI were calculated (<50% vs. >50%). RESULTS: Compared with sagittal T2 WI + DCE MRI, rFOV imaging yielded greater specificity (82.2% vs. 90.0%, positive predictive value (42.8% vs. 60.0%), and accuracy (84.0% vs. 92%) for DMI determined by reader 1 and greater the sensitivity (83.3% vs. 100%) for DMI determined by reader 2. The error of measurement of DMI as a continuous variable in millimeters did not differ significantly between the rFOV and pathology results (P < 0.21). However, there was a statistically significant difference for the DMI measured on the dynamic sequence. The DMI on DCE was greater than that seen on pathology at P = 0.02. CONCLUSION:rFOV can be used to assess DMI in clinical Stage I endometrial cancer.
Authors: Elizabeth J Moschiano; Denise A Barbuto; Christine Walsh; Kanwaljit Singh; Elizabeth D Euscher; Andres A Roma; Rouba Ali-Fehmi; Elizabeth E Frauenhoffer; Delia P Montiel; Insun Kim; Bojana Djordjevic; Anais Malpica; Sung Ran Hong; Elvio G Silva Journal: Int J Gynecol Pathol Date: 2014-05 Impact factor: 2.762
Authors: Patricia A Convery; Leigh A Cantrell; Nicola Di Santo; Gloria Broadwater; Susan C Modesitt; Angeles Alvarez Secord; Laura J Havrilesky Journal: Gynecol Oncol Date: 2011-07-13 Impact factor: 5.482
Authors: G Zaharchuk; E U Saritas; J B Andre; C T Chin; J Rosenberg; T J Brosnan; A Shankaranarayan; D G Nishimura; N J Fischbein Journal: AJNR Am J Neuroradiol Date: 2011-03-31 Impact factor: 3.825
Authors: Roberto Vargas; J Alejandro Rauh-Hain; Joel Clemmer; Rachel M Clark; Annekathryn Goodman; Whitfield B Growdon; John O Schorge; Marcela G Del Carmen; Neil S Horowitz; David M Boruta Journal: Gynecol Oncol Date: 2014-02-16 Impact factor: 5.482
Authors: Andrea Mariani; Sean C Dowdy; William A Cliby; Bobbie S Gostout; Monica B Jones; Timothy O Wilson; Karl C Podratz Journal: Gynecol Oncol Date: 2008-03-04 Impact factor: 5.482
Authors: Anika Hüsing; Laure Dossus; Pietro Ferrari; Anne Tjønneland; Louise Hansen; Guy Fagherazzi; Laura Baglietto; Helena Schock; Jenny Chang-Claude; Heiner Boeing; Annika Steffen; Antonia Trichopoulou; Christina Bamia; Michalis Katsoulis; Vittorio Krogh; Domenico Palli; Salvatore Panico; N Charlotte Onland-Moret; Petra H Peeters; H Bas Bueno-de-Mesquita; Elisabete Weiderpass; Inger T Gram; Eva Ardanaz; Mireia Obón-Santacana; Carmen Navarro; Emilio Sánchez-Cantalejo; Nerea Etxezarreta; Naomi E Allen; Kay Tee Khaw; Nick Wareham; Sabina Rinaldi; Isabelle Romieu; Melissa A Merritt; Marc Gunter; Elio Riboli; Rudolf Kaaks Journal: Eur J Epidemiol Date: 2015-05-13 Impact factor: 8.082
Authors: Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu Journal: Virchows Arch Date: 2021-02 Impact factor: 4.064